113 related articles for article (PubMed ID: 2206954)
1. High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.
Rohatiner AZ; Bassan R; Battista R; Barnett MJ; Gregory W; Lim J; Amess J; Oza A; Barbui T; Horton M
Br J Cancer; 1990 Sep; 62(3):454-8. PubMed ID: 2206954
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute lymphoblastic leukaemia in adults.
Barnett MJ; Greaves MF; Amess JA; Gregory WM; Rohatiner AZ; Dhaliwal HS; Slevin ML; Biruls R; Malpas JS; Lister TA
Br J Haematol; 1986 Nov; 64(3):455-68. PubMed ID: 3466641
[TBL] [Abstract][Full Text] [Related]
3. Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period.
Bassan R; Battista R; Rohatiner AZ; Love S; Carter M; Buelli M; Viero P; D'Emilio A; MacCallum P; Amess J
Leukemia; 1992; 6 Suppl 2():186-90. PubMed ID: 1578929
[TBL] [Abstract][Full Text] [Related]
4. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
5. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
[TBL] [Abstract][Full Text] [Related]
6. Treatment of childhood acute lymphoblastic leukemia with protocol TCL821: a report of Taiwan Children's Cancer Study Group.
Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):48-56. PubMed ID: 2666568
[TBL] [Abstract][Full Text] [Related]
7. Outcome of treatment in adult acute lymphoblastic leukaemia in an Asian population: comparison with previous multicentre German study.
Bosco I; Teh A
Leukemia; 1995 Jun; 9(6):951-4. PubMed ID: 7596183
[TBL] [Abstract][Full Text] [Related]
8. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
[TBL] [Abstract][Full Text] [Related]
9. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
[TBL] [Abstract][Full Text] [Related]
10. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia.
Kantarjian HM; Walters RS; Keating MJ; Smith TL; O'Brien S; Estey EH; Huh YO; Spinolo J; Dicke K; Barlogie B
J Clin Oncol; 1990 Jun; 8(6):994-1004. PubMed ID: 2189958
[TBL] [Abstract][Full Text] [Related]
11. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
Estlin EJ; Yule SM; Lowis SP
Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.
Kobayashi T; Tobinai K; Shimoyama M; Mikuni C; Konda S; Kozuru M; Araki K; Sai T; Fukuhara S; Matsumoto M; Aoki I; Deura K; Oyama A; Hotta T; Abe T; Toki H; Nagai M; Fukuda H; Niimi M; Yamaguchi N; Tajima K; Shirakawa S
Jpn J Clin Oncol; 1999 Jul; 29(7):340-8. PubMed ID: 10470659
[TBL] [Abstract][Full Text] [Related]
13. Intensive chemotherapy for acute lymphoblastic leukaemia in adults.
Rohatiner AZ; Bassan R; Battista R; Barnett MJ; Gregory W; Lim J; Amess J; Oza A; Barbui T; Horton M
Haematol Blood Transfus; 1990; 33():413-8. PubMed ID: 2182432
[No Abstract] [Full Text] [Related]
14. Long-term survival in acute lymphoblastic leukaemia in adults: a prospective study of 51 patients. Finnish Leukaemia Group.
Eur J Haematol; 1992 Feb; 48(2):75-82. PubMed ID: 1547879
[TBL] [Abstract][Full Text] [Related]
15. Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukemia.
Bassan R; Di Bona E; Lerede T; Pogliani E; Rossi G; D'Emilio A; Buelli M; Rambaldi A; Viero P; Rodeghiero F; Barbui T
Leuk Lymphoma; 1996 Jul; 22(3-4):295-301. PubMed ID: 8819079
[TBL] [Abstract][Full Text] [Related]
16. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK
Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
[TBL] [Abstract][Full Text] [Related]
17. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM
Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
[No Abstract] [Full Text] [Related]
[Next] [New Search]